United Laboratories India Profile
Key Indicators
- Authorised Capital ₹ 3.75 Cr
as on 16-11-2024
- Paid Up Capital ₹ 3.44 Cr
as on 16-11-2024
- Company Age 71 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 7.64 Cr
as on 16-11-2024
- Revenue 16.12%
(FY 2023)
- Profit -285.30%
(FY 2023)
- Ebitda -185.60%
(FY 2023)
- Net Worth -1.88%
(FY 2023)
- Total Assets -12.29%
(FY 2023)
About United Laboratories India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.75 Cr and a paid-up capital of Rs 3.44 Cr.
The company has closed loans amounting to ₹7.64 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sajal Roy, Rohit Misra, and Binod Misra serve as directors at the Company.
- CIN/LLPIN
U51397WB1953PTC023187
- Company No.
023187
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Nov 1953
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does United Laboratories India Pvt Ltd offer?
United Laboratories India Pvt Ltd offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antiparasitic Drug.
Who are the key members and board of directors at United Laboratories India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohit Misra  | Director | 23-Dec-2016 | Current |
| Sajal Roy | Director | 30-Apr-2013 | Current |
| Binod Misra | Director | 30-Apr-2013 | Current |
Financial Performance and Corporate Structure Insights of United Laboratories India.
United Laboratories India Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 16.12% increase. The company also saw a substantial fall in profitability, with a 285.3% decrease in profit. The company's net worth dipped by a decrease of 1.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of United Laboratories India?
In 2022, United Laboratories India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
M S Medicine House Private LimitedActive 12 years 8 monthsSajal Roy, Rohit Misra and 1 more are mutual person
- Poorba Distributors Private Limited.Active 17 years 2 months
Sajal Roy, Rohit Misra and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 26 Oct 2009 | ₹1.66 M | Satisfied |
Bank Of India Creation Date: 05 Jan 2008 | ₹6.50 M | Satisfied |
Bank Of India Creation Date: 20 Jun 2006 | ₹2.35 Cr | Satisfied |
How Many Employees Work at United Laboratories India?
Unlock and access historical data on people associated with United Laboratories India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of United Laboratories India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped United Laboratories India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
